Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.05B
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
3.29M
-
Shares change
-
-2.43M
-
Total reported value, excl. options
-
$2.91M
-
Value change
-
-$1.63M
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$0.89
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q1 2023
21 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q1 2023.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.29M shares
of 2.05B outstanding shares and own 0.16% of the company stock.
Largest 10 shareholders include Altium Capital Management LP (2.28M shares), MORGAN STANLEY (257K shares), PVG ASSET MANAGEMENT CORP (129K shares), LPL Financial LLC (118K shares), Atria Wealth Solutions, Inc. (110K shares), RENAISSANCE TECHNOLOGIES LLC (106K shares), ENVESTNET ASSET MANAGEMENT INC (98.9K shares), GEODE CAPITAL MANAGEMENT, LLC (32K shares), ADVISOR GROUP HOLDINGS, INC. (31K shares), and TWO SIGMA SECURITIES, LLC (24.2K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.